25 Aug 2023
According to a study published in the Journal of Diabetes Complications, semaglutide is more effective in helping manage type 2 diabetes than other GLP-1 receptor agonists, including greater reductions in HbA1C, body weight, waist circumference and cardiometabolic improvements.
Healio
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024